Analystreport

Biohaven (NYSE:BHVN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.

Biohaven Pharmaceutical Holding Company Ltd. Common Shares  (BHVN) 
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com